AKTS as of Nov 2 · 18:21 ET
AKTSNasdaqPharmaceutical Preparations

Aktis Oncology, Inc. · Brief

Next report

No upcoming report date.

Expected move

No implied move.

Implied vs realized

3 reportsHistory
—≥ implied
Q1 FY26—▲+8.16%—
May 11 '26—▲+7.99%—
Q2 FY26±17.0%▲+4.79%×0.28
quarterimplied−20%0+20%realized×
Q2 FY26±17.0%▲+4.79%×0.28
May '26—▲+7.99%—
Q1 FY26—▲+8.16%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Bull2

3tracked funds holding AKTSN-PORT · Aug 31 '26
113managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

0.02%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
14managers whose positions together make up four fifths of reported value13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

AKTS report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.